ARKG vs DBC

ARK Genomic Revolution ETF vs Invesco DB Commodity Index Tracking Fund

Quick take
  • ARKG has the lower expense ratio at 0.75% vs 0.85% for DBC.
  • DBC pays a higher dividend yield (2.80%).

Side-by-side metrics

MetricARKGDBC
Expense ratio
Annual fee. Lower is better.
0.75%0.85%
Dividend yield
Trailing 12-month yield.
0.00%2.80%
AUM
Assets under management — bigger funds are typically more liquid.
$1.73B$1.58B
YTD return
44.53%24.33%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.381.05
P/E ratio
6.66
Last price
$43.17$27.54
Inception
Issuer
ARKInvesco

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp9.15%
TEMTempus AI Inc Class A common stock7.64%
ABSIAbsci Corp7.01%
TXG10x Genomics Inc Ordinary Shares - Class A7.00%
CRSPCRISPR Therapeutics AG6.56%
PSNLPersonalis Inc6.19%
BEAMBeam Therapeutics Inc4.34%
GHGuardant Health Inc4.28%
NTRANatera Inc4.11%
ILMNIllumina Inc3.98%
Sector breakdown · ARKG
Healthcare100.0%

DBC top holdings

Top holdings · DBC
AGPXXInvesco Shrt-Trm Inv Gov&Agcy Instl37.02%
BRNZ26Brent Crude Future Oct 267.56%
TBLLInvesco Short Term Treasury ETF6.59%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About DBC

DBC (Invesco DB Commodity Index Tracking Fund) is Diversified commodity basket. Managed by Invesco, the fund carries $1.6B in assets under management, an expense ratio of 0.85%, a dividend yield of 2.80%. Its largest holding is Invesco Shrt-Trm Inv Gov&Agcy Instl (AGPXX), which represents 37.0% of the portfolio.